A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B

NCT06452693 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: TQA3038 injection/placebo
DRUG: Nucleotide drugs Control group

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.